ResMed is a global leader in digital health and sleep technology, specializing in the development and manufacturing of devices and software solutions for the diagnosis, treatment, and management of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, the company has grown to serve millions of patients worldwide, with operations spanning over 140 countries. ResMed’s mission is to improve quality of life, reduce the impact of chronic disease, and lower healthcare costs through innovative connected health solutions.
With a workforce exceeding 8,000 employees, ResMed combines medical device expertise with cutting-edge cloud-based software platforms to empower patients, clinicians, and healthcare providers. Its portfolio includes CPAP machines, masks, ventilators, and digital tools for remote monitoring and patient engagement. The company is recognized for its strong market position in sleep and respiratory care, and has recently expanded its digital health footprint through acquisitions and partnerships, enhancing its capabilities in home healthcare and data-driven patient management.